Excessive smokers; those who participated in another study within 30 days prior to screening; substance dependence; pregnancy; breastfeeding; intending to become pregnant within 30 days of completing the study; prolactin level of >200 ng/ml at baseline; clinically significant ECG abnormalities at screening; acute, serious, or unstable medical conditions. The gene discussed is PRL; the disease is substance dependence.